Literature DB >> 14556887

Comparison of acute hemodynamic effects of aerosolized and intravenous iloprost in secondary pulmonary hypertension in children with congenital heart disease.

Olgu Hallioglu1, Embiya Dilber, Alpay Celiker.   

Abstract

Both aerosolized and intravenous infusion of iloprost caused a significant decrease in mean pulmonary artery pressure and pulmonary vascular resistance. Although intravenous infusion caused a large decrease in mean systemic arterial pressure, this was only slightly affected by aerosolized iloprost. Aerosolized iloprost caused a significant decrease in the pulmonary-to-systemic vascular resistance ratio; however, intravenous infusion did not cause a prominent decrease in this ratio.

Entities:  

Mesh:

Substances:

Year:  2003        PMID: 14556887     DOI: 10.1016/s0002-9149(03)00991-3

Source DB:  PubMed          Journal:  Am J Cardiol        ISSN: 0002-9149            Impact factor:   2.778


  14 in total

Review 1.  Reactive oxygen and nitrogen species in pulmonary hypertension.

Authors:  Diana M Tabima; Sheila Frizzell; Mark T Gladwin
Journal:  Free Radic Biol Med       Date:  2012-03-06       Impact factor: 7.376

2.  Hemodynamic and histologic characterization of a swine (Sus scrofa domestica) model of chronic pulmonary arterial hypertension.

Authors:  Abraham Rothman; Robert G Wiencek; Stephanie Davidson; William N Evans; Humberto Restrepo; Valeri Sarukhanov; Amanda Rivera-Begeman; David Mann
Journal:  Comp Med       Date:  2011-06       Impact factor: 0.982

Review 3.  Pulmonary hypertension complicating congenital heart disease.

Authors:  J Eduardo Rame
Journal:  Curr Cardiol Rep       Date:  2009-07       Impact factor: 2.931

4.  Acute Effect of Inhaled Iloprost in Children with Pulmonary Arterial Hypertension Associated with Simple Congenital Heart Defects.

Authors:  Qiangqiang Li; Konstantinos Dimopoulos; Chen Zhang; Yan Zhu; Qian Liu; Hong Gu
Journal:  Pediatr Cardiol       Date:  2018-02-09       Impact factor: 1.655

Review 5.  Prostacyclin in the intensive care setting.

Authors:  D Dunbar Ivy
Journal:  Pediatr Crit Care Med       Date:  2010-03       Impact factor: 3.624

Review 6.  Prostacyclin for pulmonary hypertension in adults.

Authors:  N S Paramothayan; T J Lasserson; A U Wells; E H Walters
Journal:  Cochrane Database Syst Rev       Date:  2005-04-18

7.  Non-congenital heart disease associated pediatric pulmonary arterial hypertension.

Authors:  D D Ivy; J A Feinstein; T Humpl; E B Rosenzweig
Journal:  Prog Pediatr Cardiol       Date:  2009-12-01

Review 8.  Pharmacotherapy for pulmonary hypertension.

Authors:  Robin H Steinhorn
Journal:  Pediatr Clin North Am       Date:  2012-08-26       Impact factor: 3.278

Review 9.  Pulmonary arterial hypertension in children: a medical update.

Authors:  Erika B Rosenzweig; Robyn J Barst
Journal:  Indian J Pediatr       Date:  2009-04-18       Impact factor: 1.967

10.  Acute pulmonary vasodilator testing with inhaled treprostinil in children with pulmonary arterial hypertension.

Authors:  Shinichi Takatsuki; Donna K Parker; Aimee K Doran; Robert H Friesen; D Dunbar Ivy
Journal:  Pediatr Cardiol       Date:  2012-11-27       Impact factor: 1.655

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.